An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma

NCT05873959 · clinicaltrials.gov ↗

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Trauma
Trauma Injury
Trauma, Multiple
Trauma Blunt

Interventions

BIOLOGICAL: HAV implantation

Sponsor

Humacyte, Inc.